Aldeyra Therapeutics, Inc. (ALDX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.31
Day's range
$5.6

Aldeyra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KNOLL CAPITAL MANAGEMENT, LLC 02/17/2026 5.48 M $28.36 M   0.00% 9.11%
PERCEPTIVE ADVISORS LLC 02/17/2026 4.19 M $21.68 M   -19.85% 6.96%
BLACKROCK, INC. 02/12/2026 3.85 M $19.94 M   1.19% 6.40%
VANGUARD GROUP INC 01/29/2026 3.70 M $19.16 M   2.97% 6.15%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/17/2026 1.85 M $9.58 M   38.91% 3.08%
D. E. SHAW & CO., INC. 02/17/2026 1.60 M $8.29 M   16.05% 2.66%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 1.53 M $7.93 M   86.59% 2.54%
ARDSLEY ADVISORY PARTNERS LP 02/17/2026 1.45 M $7.51 M   -23.68% 2.41%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 1.26 M $6.51 M   12.91% 2.09%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 1.23 M $6.36 M   -18.50% 2.04%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.17 M $6.06 M   -0.50% 1.95%
STATE STREET CORP 02/13/2026 1.10 M $5.69 M   -0.37% 1.83%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 979.52 K $5.07 M   17.19% 1.63%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 968.75 K $5.02 M   2.24% 1.61%
MORGAN STANLEY 02/13/2026 657.03 K $3.40 M   -39.35% 1.09%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 612.26 K $3.17 M   -5.57% 1.02%
BANK OF AMERICA CORP /DE/ 02/17/2026 410.03 K $2.12 M   5.11% 0.68%
NORTHERN TRUST CORP 02/17/2026 379.41 K $1.97 M   -7.00% 0.63%
WELLS FARGO & COMPANY/MN 02/13/2026 366.17 K $1.90 M   1.30% 0.61%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 350.00 K $1.81 M   77.39% 0.58%
DEUTSCHE BANK AG\ 02/11/2026 317.34 K $1.64 M   0.83% 0.53%
GOLDMAN SACHS GROUP INC 02/10/2026 305.71 K $1.58 M   67.10% 0.51%
JANE STREET GROUP, LLC 02/12/2026 303.85 K $1.57 M   20.81% 0.51%
TWO SIGMA INVESTMENTS, LP 02/17/2026 287.36 K $1.49 M   5.24% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 268.70 K $1.39 M   231.73% 0.45%
WOODSTOCK CORP 01/14/2026 266.76 K $1.38 M   0.00% 0.44%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 263.41 K $1.36 M   2,382.63% 0.44%
CITADEL ADVISORS LLC 02/17/2026 231.20 K $1.20 M   30.11% 0.38%
PALO ALTO INVESTORS LP 02/17/2026 225.47 K $1.17 M   0.00% 0.38%
1492 CAPITAL MANAGEMENT LLC 02/10/2026 223.32 K $1.16 M   100.00% 0.37%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 178.85 K $926.45 K   -5.78% 0.30%
INVESCO LTD. 02/19/2026 163.09 K $844.79 K   21.98% 0.27%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 152.79 K $791.44 K   1.53% 0.25%
IEQ CAPITAL, LLC 02/13/2026 144.20 K $746.95 K   -9.40% 0.24%
TWO SIGMA ADVISERS, LP 02/17/2026 121.90 K $631.44 K   -33.79% 0.20%
CITADEL ADVISORS LLC 02/17/2026 121.70 K $630.41 K   685.16% 0.20%
BANK OF NEW YORK MELLON CORP 02/10/2026 115.77 K $599.67 K   -4.99% 0.19%
RUSSELL INVESTMENTS GROUP, LTD. 02/17/2026 114.13 K $591.18 K   2.72% 0.19%
NUVEEN, LLC 02/12/2026 108.22 K $560.58 K   -25.20% 0.18%
GSA CAPITAL PARTNERS LLP 02/06/2026 96.92 K $502.00 K   -20.99% 0.16%
UBS GROUP AG 01/29/2026 95.68 K $495.61 K   -52.34% 0.16%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 94.09 K $487.41 K   100.00% 0.16%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/17/2026 92.39 K $478.58 K   517.95% 0.15%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 84.93 K $439.93 K   100.00% 0.14%
BARCLAYS PLC 02/13/2026 84.47 K $437.56 K   10.21% 0.14%
GROUP ONE TRADING, L.P. 02/12/2026 83.45 K $432.27 K   -26.53% 0.14%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 81.37 K $421.48 K   33.62% 0.14%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/17/2026 76.37 K $395.57 K   66.29% 0.13%
ALLIANCEBERNSTEIN L.P. 02/17/2026 75.55 K $391.35 K   0.00% 0.13%
RHUMBLINE ADVISERS 02/13/2026 70.41 K $364.73 K   -10.47% 0.12%

Aldeyra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 177 institutional investors and hedge funds held shares of Aldeyra Therapeutics Inc. The most heavily invested institutionals were:

Knoll Capital Management, LLC: 5.48 M

PERCEPTIVE ADVISORS LLC: 4.19 M

BlackRock, Inc.: 3.85 M

VANGUARD GROUP INC: 3.7 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.85 M

D. E. Shaw & Co., Inc.: 1.6 M

64.75% of Aldeyra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 44.32 M shares in the last 24 months. This purchase volume represents approximately $239.78 M in transactions.